Chief Executive Officer · SELECT MEDICAL HOLDINGS CORP (SEM)

Thomas Mullin

A named executive officer of SELECT MEDICAL in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$3,042,527

FY2024: $4,842,138

4th of 6 named executive officers at Select Medical by FY2025 total.

6 named officers on file for SELECT MEDICAL, FY2025

See an example →

What this number hides

The filing gives the total. SELECT MEDICAL’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed March 4, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-07.

Free

Get Thomas Mullin’s full pay file as a PDF — free

More than this page: up to 10 years of Thomas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Thomas Mullin and every company like it: Velarion Intel, free for 3 days, no card →

Thomas Mullin compensation by year

SELECT MEDICAL Summary Compensation Table · all 2 fiscal years held
In US dollars, as SELECT MEDICAL reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$615,808$618,000
Stock awards$2,837,000$1,425,000
Option awards$0$0
Non-equity incentive$1,236,000$939,360
Pension and deferred compensation$0$0
All other$153,330$60,167
Total$4,842,138$3,042,527

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SELECT MEDICAL HOLDINGS CORP DEF 14A filed March 4, 2026, accession 0001104659-26-023205, and prior-year filings.

How this page was built: the SELECT MEDICAL HOLDINGS CORP filed document, accession 0001104659-26-023205. Every figure is read from that document and cited to the page and table it appears in. Filed March 4, 2026.

$4.8M
$3.0M
FY24
FY25
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU100,000$1,485,000—
RSU66,667$990,005—
RSU50,000$742,500—

Per the Outstanding Equity Awards at Fiscal Year-End table in SELECT MEDICAL HOLDINGS CORP's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2025 proxy (filed March 4, 2026)
current to 2026-11-07 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-30Other—391,709$0.000

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

SELECT MEDICAL’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Robert OrtenzioExecutive Chairman and Co-Founder$6,615,969
David ChernowVice Chairman$6,542,405
Martin JacksonSenior Executive Vice President of Strategic Finance and Operations$4,011,191
Thomas Mullin · this pageChief Executive Officer$3,042,527
John SaichPresident$3,035,527
Michael MalatestaExecutive Vice President and Chief Financial Officer$2,581,347

The full SELECT MEDICAL compensation record

free company brief

This page is one person within SELECT MEDICAL's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order SELECT MEDICAL's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are SELECT MEDICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Thomas Mullin's compensation dossier